These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
621 related items for PubMed ID: 18186007
1. [Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication]. Hohl-Radke F, Aedtner F, Domröse U, Neumann KH, Staedt J. Dtsch Med Wochenschr; 2008 Jan; 133(3):71-5. PubMed ID: 18186007 [Abstract] [Full Text] [Related]
3. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. García-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ, International Restless Legs Syndrome Study Group. Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323 [Abstract] [Full Text] [Related]
4. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome. Bliwise DL, Freeman A, Ingram CD, Rye DB, Chakravorty S, Watts RL. Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217 [Abstract] [Full Text] [Related]
5. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients. Hornyak M, Hundemer HP, Quail D, Riemann D, Voderholzer U, Trenkwalder C. Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532 [Abstract] [Full Text] [Related]
6. Restless legs syndrome in patients on dialysis. Al-Jahdali HH, Al-Qadhi WA, Khogeer HA, Al-Hejaili FF, Al-Ghamdi SM, Al Sayyari AA. Saudi J Kidney Dis Transpl; 2009 May; 20(3):378-85. PubMed ID: 19414938 [Abstract] [Full Text] [Related]
9. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies. Fulda S, Wetter TC. Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100 [Abstract] [Full Text] [Related]
11. Clinical characteristics of restless legs syndrome in end-stage renal failure and idiopathic RLS patients. Enomoto M, Inoue Y, Namba K, Munezawa T, Matsuura M. Mov Disord; 2008 Apr 30; 23(6):811-6; quiz 926. PubMed ID: 18074382 [Abstract] [Full Text] [Related]
12. Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Winkelmann J, Stautner A, Samtleben W, Trenkwalder C. Mov Disord; 2002 Sep 30; 17(5):1072-6. PubMed ID: 12360562 [Abstract] [Full Text] [Related]
13. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements. Manconi M, Ferri R, Zucconi M, Oldani A, Fantini ML, Castronovo V, Ferini-Strambi L. Sleep Med; 2007 Aug 30; 8(5):491-7. PubMed ID: 17512780 [Abstract] [Full Text] [Related]
14. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease. Nomura T, Inoue Y, Nakashima K. J Neurol Sci; 2006 Dec 01; 250(1-2):39-44. PubMed ID: 16899256 [Abstract] [Full Text] [Related]
15. Pediatric restless legs syndrome and periodic limb movement disorder: parent-child pairs. Picchietti DL, Rajendran RR, Wilson MP, Picchietti MA. Sleep Med; 2009 Sep 01; 10(8):925-31. PubMed ID: 19332386 [Abstract] [Full Text] [Related]
19. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. Frauscher B, Gschliesser V, Brandauer E, El-Demerdash E, Kaneider M, Rücker L, Poewe W, Högl B. Sleep Med; 2009 Jun 01; 10(6):611-5. PubMed ID: 19200780 [Abstract] [Full Text] [Related]
20. Factors potentiating the risk of mirtazapine-associated restless legs syndrome. Kim SW, Shin IS, Kim JM, Park KH, Youn T, Yoon JS. Hum Psychopharmacol; 2008 Oct 01; 23(7):615-20. PubMed ID: 18756499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]